SCHEMBL6888047

SCHEMBL6888047

CCCCCc1cc(O)c2c3c(C(=O)OC)cccc3n(Cc3cccc(Cc4ccccc4)c3)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.38
CNR2 P34972 2/20 0.38
MAPK8 P45983 1/20 0.38
PLK1 P53350 1/20 0.36
PPARA Q07869 1/20 0.36
AGTR1 P30556 1/20 0.36
AGTR2 P50052 1/20 0.36
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
USP2 O75604 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5212605 0.94 MAPK8 (0.42) MAPK8PLK1PPARAAGTR1AGTR2
SCHEMBL6889205 0.91 MAPK8 (0.41) MAPK8PLK1PPARAAGTR1AGTR2
SCHEMBL6896241 0.91 CNR1 (0.42) CNR1CNR2MAPK8PLK1PPARA
SCHEMBL6897434 0.91 MAPT (0.39) ALDH1A1GAAMAPTPKMKDM4E
SCHEMBL6897075 0.90 CETP (0.41) PPARAALDH1A1PPARG
SCHEMBL6896800 0.89 MAPT (0.43) CNR1CNR2AGTR1ALDH1A1GAA
SCHEMBL6776320 0.89 PPARG (0.41) CNR1CNR2PLK1PPARAGPR55
SCHEMBL6891901 0.88 PLA2G2A (0.43) CNR1CNR2AGTR1MAPT
SCHEMBL6889327 0.88 MAPT (0.41) CNR2ALDH1A1GAAMAPTTRPV1
SCHEMBL6897945 0.88 POLB (0.36) MAPK8PLK1PPARAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed